GeneDx Holdings (WGS) Stock Price

GeneDx Holdings Price

NASDAQ·CLOSED
68.53
​
Market closed

Over the last 7 years GeneDx Holdings grew revenue by 18.1% annually, reaching 427.54 M USD. For GeneDx Holdings, the net margin of -4.9% is up versus -115.6% a few years ago. The consensus 12-month price target for GeneDx Holdings is 85.00 USD, about 24.0% above where the stock trades today. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus.

GeneDx Holdings stock price

Access this data via the Eulerpool API

GeneDx Holdings business model & stock analysis

GeneDx Holdings Corp. is a patient centered health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,100 full-time employees. The company went IPO on 2020-09-04. The firm is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company’s segments are GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women’s health and somatic oncology diagnostic testing and screening products.

Frequently asked questions about GeneDx Holdings

Analysts currently set an average price target of 89.57 USD for the GeneDx Holdings stock (median: 85.00 USD), implying +30.7 % versus the latest price. The consensus is based on 13 analyst ratings.

13 analysts currently rate the GeneDx Holdings stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect GeneDx Holdings to generate revenue of 482.28 M USD and earnings per share of 0.11 USD.

Converted at the current exchange rate, the GeneDx Holdings share trades at 61.15 EUR (68.53 USD).

The GeneDx Holdings share (WGS) is listed on 1 stock exchanges, including: NASDAQ (WGS).

The expected revenue of GeneDx Holdings is 482.28 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of GeneDx Holdings is 2.89 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of GeneDx Holdings is currently 637.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the GeneDx Holdings stock.

The price-to-sales ratio (P/S) of GeneDx Holdings is currently 3.82. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the GeneDx Holdings stock.

The Eulerpool Quality Score for GeneDx Holdings is 3/10.

The ISIN of GeneDx Holdings is US81663L2007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of GeneDx Holdings is WGS. The ticker symbol is used to trade GeneDx Holdings shares on the stock exchange.

Fair ValueTerminal
58.25 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
328,876.15 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website sema4.com
Currency
USD
Initial public offering
Sep 4, 2020
ISIN
US81663L2007
Cusip
81663L200
Market capitalization
1.98 B USDSmall Cap
52-Week Range
PEG
-0.73
P/E ratio
P/Ee 2026
685.30
P/Ee 2027
57.18
P/Ee 2028
38.50
P/Ee 2029
22.69
P/Ee 2030
13.42
P/S
P/Se
3.82
EV/EBIT
—
P/B Ratio
6.43
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5.75 %
Last updated Oct 9, 2026, 8:27 AM

GeneDx Holdings Peer Group

GeneDx Holdings Ticker

NASDAQ · WGS

GeneDx Holdings FIGI

WGS:US · BBG00XDHY5P9WGS:UA · BBG00XZQM0Z8WGS:UC · BBG00XZQM104WGS:UN · BBG00XZQM122WGS:UP · BBG00XZQM131WGS:UB · BBG00XZQM159WGS:UM · BBG00XZQM177WGS:UX · BBG00XZQM186WGS:UD · BBG00XZQM1F8WGS:UW · BBG00XZQM1H6WGS:UF · BBG00XZQM1J4WGS:VY · BBG00XZQM1K2